
Journal of Medicinal Chemistry p. 137 - 149 (1995)
Update date:2022-08-04
Topics:
Kolodziej, Stephen A.
Nikiforovich, Gregory V.
Skeean, Richard
Lignon, Marie-Francoise
Martinez, Jean
Marshall, Garland R.
It has been reported that substitution of the Met31 residue in Boc-CCK4 (Boc-Trp30-Met31-Asp32-Phe33-NH2, CCK33 numbering) by trans-3-propyl-L-proline yields a highly potent and selective CCK-B agonist.To further explore the structural requirements of the Met31 side chain in the receptor-bound conformation of CCK4, we have synthesized several Ac-CCK4 analogs containing substitution of Met31 by 3- and 4-(alkylthio)-substituted proline derivatives.To this end we have developed novel synthetic routes to enantiomerically pure N-Boc-4-cis- and -trans-(methylthio)prolines and racemic N-Boc-3-cis- and -trans-<(4-methylbenzyl)thio>prolines.The protected mercaptoprolines were incorporated into Ac-CCK4 analogs using SPPS and were alkylated using various electrophiles following cleavage from the solid support.Binding assays reveal that 3-(alkylthio)prolines analogs have higher affinities at the CCK-B receptor than the corresponding 4-(alkylthio)proline analogs, and that trans-3-(alkylthio)proline analogs had higher affinities than corresponding cis-3-(alkylthio)proline analogs.Within both the cis- and trans-3-(alkylthio)proline series, the order of potency was found to be Me < Et < n-Pr.The trans-3-(n-propylthio)-L-proline analog demonstrates a higher affinity than that reported for Boc-CCK4
Contact:+44 (0)161 367 9441
Address:
Zhejiang Linhai Xinhua Chemicals Factory
Contact:0086-13661858911
Address:Xunqiao Development Zone, Linhai, Zhejiang, China
NINGBO YINLIANG FOREIGN TRADE CO., LTD.
Contact:+86-574-87834016 / 87898057
Address:23F NO.666JINYU ROAD,YINGZHOU DISTRICT,NINGBO.CHINA
Compro Shijiazhuang Fine Chemical Co., Ltd
Contact:0086-311-89689838
Address:Economic and Technological Development Zone of Shijiazhuang,Hebei
Shanghai Taibao Pharmaceutical Technology Co., Ltd(expird)
Contact:021-52217366
Address:shanghai
Doi:10.1007/BF02495930
(1997)Doi:10.1039/P19810001424
(1981)Doi:10.1021/jm00142a021
(1981)Doi:10.1021/jo00335a002
(1981)Doi:10.1016/j.bmc.2008.01.047
(2008)Doi:10.1021/ja00127a038
(1995)